Campus Biotech today hosted the second annual summit on the future of healthcare, organised by the Swiss newspaper Le Temps and by Politico, the global nonpartisan politics and policy news organisation. As well as Campus Biotech as the conference's venue partner, the meeting was supported by Ferring Pharmaceuticals, Merck, Roche, Emergent Biosolutions and by Air Liquide Healthcare.
Global policy makers and representatives from industry and patients came together to debate key issues in healthcare today, globally: What is the future of government drug pricing in Europe? How will it impact pharma companies? What regulatory improvements can increase health promotion and disease prevention? How can governments address the lack of market incentives for costly health technologies?
Speakers includes Vytenis Andriukaitis, the Commissioner for Health and Food Safety at the European Commission, Sally Davies, the UK’s Chief Medical Officer, Karl Brauner, Deputy Director-General at the World Trade Organization, Nicola Bedlington from the European Patients’ Forum, Fumie Griego from the International Federation of Pharmaceutical Manufacturers and Associations, Ilona Kickbusch, the Director of the Global Health Centre at the Graduate Institute of Geneva, and Henry Markram, founder and Director of the Blue Brain Project, which is housed here at Campus Biotech.
In discussing some of the most pressing and most difficult questions faced in healthcare today, the conference’s panels and its audience thus represented views from across the spectrum. In this, Campus Biotech was proud to welcome the summit, proud to host the valuable and healthy debate that it gave rise to and thankful to Le Temps and to Politico for bringing it together.